Skip to content

The HealthyMoms Trial to Promote Healthy Gestational Weight Gain

A Smartphone Application (HealthyMoms) to Promote Healthy Weight Gain, Diet and Physical Activity During Pregnancy: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03298555
Enrollment
305
Registered
2017-10-02
Start date
2017-10-01
Completion date
2020-11-04
Last updated
2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Mothers, Weight Gain

Brief summary

Excessive gestational weight gain is a major public health problem. Traditional face-to-face intervention programs has been shown to be succesful in order to promote healthier weight gains, however, they are time-consuming and expensive. The objectives of this study are to assess whether a 6-month smartphone application can promote healthy gestational weight gain, dietary habits and physical activity in pregnant women.

Detailed description

Excessive gestational weight gain (GWG) increases risks for pregnancy complications, postpartum weight retention and offspring obesity. Traditional intervention programs are time and cost intensive. Mobile technology (mHealth) has been successful for weight loss and behavior changes; however, their use in pregnancy need to be further examined. This study aims to evaluate the impact of a smartphone application (app) intervention on GWG, diet, physical activity and glucose homeostasis. HealthyMoms is a randomized controlled trial recruiting women at the first maternity clinic visit (week 6-10) in the Linköping area, Sweden. Women will be randomized to the control or intervention group (n=150 per group). All women will receive standard care. The intervention group will also receive the HealthyMoms smartphone app promoting healthy eating, activity and GWG during 6 months. Pregnancy outcomes are GWG (primary), food intake (web-based questionnaire), fat mass (BodPod), glucose homeostasis, activity (accelerometer) in week 37. Maternal and infant body fatness will be assessed one week post partum.

Interventions

Participants in the intervention group will receive a 6-month mobile phone based program via a mobile phone application specifically designed for this study. The program will include information, advice and strategies to promote healthy gestational weight gain.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* a single pregnancy * aged 18 years or above * be able to speak and read Swedish sufficiently well.

Exclusion criteria

* previous diagnosed eating disorder * pre-pregnancy diabetes or medical conditions or pharmacological treatments prior to pregnancy that may affect body weight

Design outcomes

Primary

MeasureTime frameDescription
Gestational weight gainAt the end of the intervention which is 23 weeks after baselineBody weight in gestational week 37 minus body weight in gestational week 14

Secondary

MeasureTime frameDescription
Physical activity using accelerometryAt the end of the intervention which is 23 weeks after baselineModerate-to-vigorous physical activity (MVPA) in gestational week 37 minus MVPA in gestational week 14. MVPA will be assessed using wrist-worn accelerometry (Actigraph wGT3x) during 7 days at both time points.
Diet quality using a web-based questionnaireAt the end of the intervention which is 23 weeks after baselineDiet quality in gestational week 37 minus diet quality in gestational week 14. Diet quality will be assessed using a web-based questionnaire (a combination of a food-frequency questionnaire and two 24 hour recalls)
Body fatness using air-displacement plethysmographyAt the end of the intervention which is 23 weeks after baselineBody fatness in gestational week 37 minus body fatness in gestational week 14
Maternal body fatness post partumOne week post partumMaternal body fatness 1 week post partum
Infant body fatnessOne week of ageInfant body fatness at 1 week of age
GlycemiaAt the end of the intervention which is 23 weeks after baselinePlasma glucose levels in gestational week 37 minus plasma glucose levels in gestational week 14

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026